Dimensional Fund Advisors
LYRA

Dimensional Fund Advisors’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Dimensional Fund Advisors’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-429
Closed -$5.94K – 3368
2024
Q2 		$5.94K Sell
429
-3,391
-89% -$383K ﹤0.01% 3373
2024
Q1 		$1.19M Buy
3,820
+1,567
+70% +$418K ﹤0.01% 2893
2023
Q4 		$590K Buy
2,253
+1,688
+299% +$305K ﹤0.01% 3015
2023
Q3 		$110K Buy
+565
New +$101K ﹤0.01% 3302

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors's LYRA Position: Q3 2024 in Review

Dimensional Fund Advisors sold out of LYRA THERAPEUTICS INC (LYRA) in Q3 2024, closing a stake of 429 shares — an estimated $5.94K sold.

Dimensional Fund Advisors first reported a position in LYRA in Q3 2023 and held it in 4 quarters. The position peaked at $1.19M in Q1 2024. 62 funds tracked by Wall St. Rank hold LYRA as of Q3 2024.

  • Dimensional Fund Advisors reported no remaining LYRA THERAPEUTICS INC position as of Q3 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 429 LYRA THERAPEUTICS INC shares in Q3 2024, an estimated $5.94K.
  • Dimensional Fund Advisors first reported a position in LYRA THERAPEUTICS INC in Q3 2023 and held it in 4 quarters.
  • Dimensional Fund Advisors's LYRA THERAPEUTICS INC position peaked at $1.19M in Q1 2024.
  • 62 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q3 2024.

Based on Dimensional Fund Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.